CS logo
small CS logo
KLIMED Marek Klimkiewicz

Bialystok, Poland

About KLIMED Marek Klimkiewicz


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
4
Boehringer Ingelheim
3
Bayer
2
Eli Lilly and Company
2
Hoffmann-La Roche
2
Daiichi Sankyo, Inc.
1
Fresenius Kabi SwissBioSim GmbH
1
Total Rows: 7

Clinical Trials at KLIMED Marek Klimkiewicz


During the past decade, KLIMED Marek Klimkiewicz conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 7 clinical trials were completed, i.e. on average, 46.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11550033002233110000002211221111Started TrialsCompleted Trails201620172018201920202021202220230246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment

Rows per page:

0–0 of 0

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "KLIMED Marek Klimkiewicz" #1 sponsor was "Pfizer" with 4 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Bayer" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "KLIMED Marek Klimkiewicz" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 4Pfizer: 4Boehringer Ingelheim: 3Boehringer Ingelheim: 3Bayer: 2Bayer: 2Eli Lilly and Company: 2Eli Lilly and Company: 2Hoffmann-La Roche: 2Hoffmann-La Roche: 2Daiichi Sankyo, Inc.: 1Daiichi Sankyo, Inc.: 1Fresenius KabiSwissBioSim GmbH: 1Fresenius KabiSwissBioSim GmbH: 1

Created with Highcharts 11.1.0Top CollaboratorsEli Lilly and Company: 2Eli Lilly and Company: 2Quintiles, Inc.: 1Quintiles, Inc.: 1

Clinical Trials Conditions at KLIMED Marek Klimkiewicz


According to Clinical.Site data, the most researched conditions in "KLIMED Marek Klimkiewicz" are "Heart Failure" (4 trials), "Atrial Fibrillation" (2 trials), "COVID-19" (2 trials), "Alzheimer Disease" (1 trials) and "Alzheimers Disease" (1 trials). Many other conditions were trialed in "KLIMED Marek Klimkiewicz" in a lesser frequency.

Clinical Trials Intervention Types at KLIMED Marek Klimkiewicz


Most popular intervention types in "KLIMED Marek Klimkiewicz" are "Drug" (15 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Empagliflozin" (2 trials), "PF-07321332" (2 trials), "Ritonavir" (2 trials) and "0 mg Induction ONLY" (1 trials). Other intervention names were less common.

Clinical Trials Genders at KLIMED Marek Klimkiewicz


The vast majority of trials in "KLIMED Marek Klimkiewicz" are 15 trials for "All" genders.

Clinical Trials Status at KLIMED Marek Klimkiewicz


Currently, there are NaN active trials in "KLIMED Marek Klimkiewicz". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in KLIMED Marek Klimkiewicz, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in KLIMED Marek Klimkiewicz, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 11Phase 3: 11Phase 2: 4Phase 2: 4Not Applicable: 1Not Applicable: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 9Completed: 9Recruiting: 4Recruiting: 4Terminated: 2Terminated: 2